Issue navigation
Volume 60, Issue 4, October 2007
Leading Articles
Improving practice—the Hospital Pharmacy Initiative revisited
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 709–711, https://doi.org/10.1093/jac/dkm250
Improving practice—working together to improve the use of antimicrobials
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 712–714, https://doi.org/10.1093/jac/dkm335
Review
Macrolide-resistant Campylobacter: the meat of the matter
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 715–723, https://doi.org/10.1093/jac/dkm300
Systematic review
Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 724–732, https://doi.org/10.1093/jac/dkm302
Original Articles
Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998–2004)
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 733–740, https://doi.org/10.1093/jac/dkm273
The carbohydrate-binding plant lectins and the non-peptidic antibiotic pradimicin A target the glycans of the coronavirus envelope glycoproteins
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 741–749, https://doi.org/10.1093/jac/dkm301
Investigation of conditions involved in the susceptibility of the dermatophyte Trichophyton rubrum to photodynamic treatment
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 750–759, https://doi.org/10.1093/jac/dkm304
Bactericidal efficacy of liposomal aminoglycosides against Burkholderia cenocepacia
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 760–769, https://doi.org/10.1093/jac/dkm289
Determination of disc breakpoints and evaluation of Etests for tigecycline susceptibility testing by the BSAC method
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 770–774, https://doi.org/10.1093/jac/dkm297
Occurrence of antimicrobial resistance in bacteria from diagnostic samples from dogs
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 775–781, https://doi.org/10.1093/jac/dkm269
In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 782–787, https://doi.org/10.1093/jac/dkm295
Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001–05
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 788–794, https://doi.org/10.1093/jac/dkm258
Dose-related selection of fluoroquinolone-resistant Escherichia coli
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 795–801, https://doi.org/10.1093/jac/dkm265
In vivo studies on the antileishmanial activity of buparvaquone and its prodrugs
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 802–810, https://doi.org/10.1093/jac/dkm303
Antimalarial pharmacodynamics and pharmacokinetics of a third-generation antifolate—JPC2056—in cynomolgus monkeys using an in vivo–in vitro model
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 811–818, https://doi.org/10.1093/jac/dkm280
Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 819–823, https://doi.org/10.1093/jac/dkm271
Impact of steady-state lopinavir plasma levels on plasma lipids and body composition after 24 weeks of lopinavir/ritonavir-containing therapy free of thymidine analogues
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 824–830, https://doi.org/10.1093/jac/dkm285
Amprenavir and ritonavir plasma concentrations in HIV-infected patients treated with fosamprenavir/ritonavir with various degrees of liver impairment
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 831–836, https://doi.org/10.1093/jac/dkm282
Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 837–842, https://doi.org/10.1093/jac/dkm294
Trends of prevalence of primary HIV drug resistance in Germany
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 843–848, https://doi.org/10.1093/jac/dkm274
Outbreak of hospital-adapted clonal complex-17 vancomycin-resistant Enterococcus faecium strain in a haematology unit: role of rapid typing for early control
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 849–854, https://doi.org/10.1093/jac/dkm270
Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 855–863, https://doi.org/10.1093/jac/dkm279
BRIEF REPORTS
Nucleotide sequence and transfer properties of two novel types of Actinobacillus pleuropneumoniae plasmids carrying the tetracycline resistance gene tet(H)
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 864–867, https://doi.org/10.1093/jac/dkm293
Prevalence and diversity of qnr alleles in AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii and Serratia marcescens: a multicentre study from Korea
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 868–871, https://doi.org/10.1093/jac/dkm266
Most Escherichia coli strains overproducing chromosomal AmpC β-lactamase belong to phylogenetic group A
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 872–876, https://doi.org/10.1093/jac/dkm284
Biochemical analysis of TEM-134, a new TEM-type extended-spectrum β-lactamase variant produced in a Citrobacter koseri clinical isolate from an Italian hospital
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 877–880, https://doi.org/10.1093/jac/dkm275
Detection and quantification of minority HIV isolates harbouring the D30N mutation by real-time PCR amplification
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 881–884, https://doi.org/10.1093/jac/dkm281
Prevalence of darunavir resistance mutations in HIV-1-infected patients failing other protease inhibitors
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 885–888, https://doi.org/10.1093/jac/dkm276
Decreased susceptibility of Candida albicans to azole antifungals: a complication of long-term treatment in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 889–892, https://doi.org/10.1093/jac/dkm299
Diffusion of ertapenem into bone and synovial tissues
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 893–896, https://doi.org/10.1093/jac/dkm296
Therapeutic drug monitoring of the HIV protease inhibitor atazanavir in clinical practice
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 897–900, https://doi.org/10.1093/jac/dkm298
Correspondence
Comment on: Best in class: a good principle for antibiotic usage to limit resistance development?
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Page 901, https://doi.org/10.1093/jac/dkm278
Best in class: a good principle for antibiotic usage to limit resistance development?—author's response
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 901–902, https://doi.org/10.1093/jac/dkm339
Comment on: Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 902–903, https://doi.org/10.1093/jac/dkm290
Complete nucleotide sequence of a small qnrS1-carrying plasmid from Salmonella enterica subsp. enterica Typhimurium DT193
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 903–905, https://doi.org/10.1093/jac/dkm283
Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study—authors' response
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Page 903, https://doi.org/10.1093/jac/dkm333
Activity of iclaprim against Legionella pneumophila
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 905–906, https://doi.org/10.1093/jac/dkm288
High prevalence of CTX-M-15 extended-spectrum β-lactamase among contacts of patients with shigellosis due to Shigella flexneri carrying CTX-M-15
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 906–908, https://doi.org/10.1093/jac/dkm277
Marked increase in steady-state serum levels achieved with itraconazole oral solution compared with capsule formulation
Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, October 2007, Pages 908–909, https://doi.org/10.1093/jac/dkm272
